AC Immune SA (NASDAQ:ACIU) has 46 institutional investors that have filed 13F reports for the period ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BVF INC/IL | 31 Mar, 2026 | 19,822,436 | 0 | 0.00% | $54,511,699.00 |
| Wells Fargo & Company/Mn | 31 Mar, 2026 | 1,004,284 | -2,005 | -0.20% | $2,761,781.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 792,657 | -140,685 | -15.07% | $2,179,807.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 624,367 | -44,500 | -6.65% | $1,717,009.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 524,278 | 22,109 | 4.40% | $1,441,766.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Mar, 2026 | 405,658 | 30,035 | 8.00% | $1,115,560.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 390,165 | 176,701 | 82.78% | $1,071,088.00 |
| Northern Trust Corp | 31 Mar, 2026 | 278,513 | -3,440 | -1.22% | $765,911.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 267,233 | 196,082 | 275.59% | $734,891.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 131,458 | -55,251 | -29.59% | $361,511.00 |
| Dauntless Investment Group, LLC | 31 Mar, 2026 | 107,489 | -8,188 | -7.08% | $295,595.00 |
| UBS Group AG | 31 Mar, 2026 | 101,629 | -92,720 | -47.71% | $279,480.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Mar, 2026 | 96,907 | -367,790 | -79.15% | $266.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Mar, 2026 | 89,262 | -58,363 | -39.53% | $245,471.00 |
| Morgan Stanley | 31 Mar, 2026 | 89,253 | -5,092 | -5.40% | $245,446.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 63,601 | 0 | 0.00% | $174,902.00 |
| JANE STREET GROUP, LLC | 31 Mar, 2026 | 57,696 | 46,986 | 438.71% | $158,664.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 39,091 | -48,793 | -55.52% | $107,500.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 21,632 | -15,478 | -41.71% | $59,488.00 |
| China Universal Asset Management Co., Ltd. | 31 Mar, 2026 | 17,852 | 1,490 | 9.11% | $49,093.00 |